Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in a Community-Based Primary Care Setting

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The goal of this observational study is to investigate the prevalence and risk factors of hyperkalemia in community-based non-dialysis chronic kidney disease (CKD) patients. The main questions it aims to answer are: 1. What is the prevalence of hyperkalemia in non-dialysis CKD patients in a primary care setting? 2. What are the key risk factors influencing the occurrence of hyperkalemia in this population? Researchers will collect clinical and demographic data from participants across 18 community health centers and use both point-of-care testing (POCT) and laboratory-based methods to measure serum potassium levels and related parameters. Participants will: 1. Provide blood samples for POCT and laboratory testing. 2. Participate in interviews or questionnaires to gather clinical and lifestyle information. The findings will be used to construct a risk prediction model for hyperkalemia, aiming to optimize screening pathways and improve disease management strategies in primary care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Aged 18 years or older with stable vital signs, specifically defined as:

‣ Body temperature: 36.0°C-38.0°C;

⁃ Pulse: 50-120 beats/min;

⁃ Respiratory rate: 10-24 breaths/min;

⁃ Blood pressure: Systolic blood pressure ≥90 mmHg and diastolic blood pressure ≥60 mmHg.

• Willing to participate in the study and sign the informed consent form.

• Hematocrit (Hct) level between 25% and 60%.

• Confirmed diagnosis of chronic kidney disease (CKD).

Locations
Other Locations
China
Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
RECRUITING
Shanghai
Contact Information
Primary
Xiujuan Zang, MD
zangxiujuan@shsmu.edu.cn
+8618918289268
Backup
Xiangyu Zhang, MMed
zhang_xiangyu@126.com
+8618963755366
Time Frame
Start Date: 2025-04-28
Estimated Completion Date: 2025-09-30
Participants
Target number of participants: 1890
Related Therapeutic Areas
Sponsors
Leads: Xiujuan Zang

This content was sourced from clinicaltrials.gov